NeoBase 2 Succinylacetone Assay Solution 3046-0010

GUDID 06438147356829

NeoBase™ 2 Succinylacetone Assay Solution is intended for in vitro diagnostic use with the NeoBase 2 Non-derivatized MSMS kit and the NeoBase2 Non-derivatized Assay Solutions to extract succinylacetone from blood samples dried on filter paper.

Wallac Oy

Multiple amino acid/carnitine metabolite IVD, kit, mass spectrometry
Primary Device ID06438147356829
NIH Device Record Keydd8880c7-97fd-4fca-9cd5-ff04b7320cf7
Commercial Distribution StatusIn Commercial Distribution
Brand NameNeoBase 2 Succinylacetone Assay Solution
Version Model Number3046-0010
Catalog Number3046-0010
Company DUNS540156544
Company NameWallac Oy
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius
Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS106438147356829 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

NQLSystem, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number2
Public Version Date2020-04-30
Device Publish Date2019-02-25

Devices Manufactured by Wallac Oy

06438147385478 - RESOLVE Hb FACS Control kit2023-04-25 A control for monitoring assay performance in isoelectric focusing techniques used for identifying hemoglobin variants.
06438147386918 - Buffer M2023-04-25
06438147386956 - DBS Controls M22023-04-25 The DBS Controls M2 is intended for use as an external control material to evaluate the performance of lysosomal enzyme activity
06438147386963 - Iduronate 2-sulfatase S&IS2023-04-25 Vials contain Iduronate 2-sulfatase -substrate and Iduronate 2-sulfatase -internal standard, which can be used to measure the Id
06438147371815 - Qsight 210 MD Screening System2023-04-06
06438147384709 - Qsight 225 MD Screening System2023-04-06
06438147373901 - Eonis Analysis software2022-12-12 The Eonis Analysis Software is intended for in vitro diagnostic use for analysis of the real time PCR data generated usingthe Eo
06438147377718 - Eonis DNA Extraction kit2022-12-08 The Eonis DNA Extraction kit is a device intended for isolation and purification of DNA in newborn blood specimens dried on filt

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.